CD4 and neoplasm: Having found that the protein α1PI promotes migration of immature DPs and mature CD4+ T cells through tissue in humans, we sought to develop an orally available small molecule, Alphataxin, to act as a surrogate for α1PI in addressing the effects of CD4+ T cells on tumor killing function (17).